Strategic Initiative

Slingshot members are tracking this corporate initiative:

Sanofi (SNY) and Alnylam (ALNY) Agree to Co-Develop and Commercialize RNAi Therapeutic Fitusiran in Treatment of Hemophilia and Rare Bleeding Disorders

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SNY

100%
ALNY

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Nov 14, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Development, Commercialization, Fitusiran, Hemophilia, Rare Bleeding Disorders